Urology

First-line treatments for erectile dysfunction are under-prescribed in patients with prostate cancer, despite favourable clinical outcomes.

SBRT was linked to lower biochemical failure and fewer acute urinary adverse events than HDR brachytherapy in intermediate-risk prostate cancer.

Randomised data show leuprolide is linked to greater 12-month coronary plaque progression than relugolix in men receiving ADT for prostate cancer.

Higher levels of leisure-time physical activity after cancer diagnosis were associated with lower cancer mortality in survivors of several tumour types.

Salvage focal therapy delivers similar 10-year survival to surgery in radiorecurrent prostate cancer, with significantly fewer perioperative complications.

Modified water vapour thermal therapy significantly improved symptoms, urinary flow, and quality of life in men with large-volume BPH, with low complication rates.

Automated urinary incontinence screening in primary care increased diagnoses and pelvic floor therapy referrals among more than 72,000 women in a US quality-improvement study.

A systematic review reveals how gut microbiota changes, inflammation, and intestinal barrier dysfunction may influence benign prostatic hyperplasia development.